Diagnoly

Diagnoly is a French DeepTech company focused on AI-powered medical software to enhance fetal ultrasound screening. Founded in 2020 by Ivan Voznyuk and Dr. Edwin Quarello, the company addresses the challenge of undetected fetal pathologies by improving the accuracy and consistency of obstetric ultrasound examinations through real-time AI assistance. The flagship product, Fetoly, is an AI ultrasound assistant that connects to existing ultrasound devices, providing continuous analysis during fetal examinations. It evaluates over 100 anatomical landmarks and quality criteria based on ISUOG guidelines, automating tasks like freezing ultrasound views and detecting more than 90% of major fetal cardiac pathologies. This technology aims to reduce operator dependency and variability in ultrasound interpretation, supporting healthcare professionals in making timely and accurate decisions. Diagnoly targets healthcare providers in prenatal mother-fetal medicine and women’s health, including obstetricians and sonographers. The company emphasizes data privacy by performing all analyses on-device, ensuring patient confidentiality. Fetoly is set to be available in clinical settings across the US and Europe in 2025.

• Employees 15
• Founded 2020